Table 1.
Mean of Mapped Reads per Sample | % of Reads On Target | Average of Mapped Reads, On Target per Sample | Mean Depth (On Target) | Coverage Uniformity | ||
---|---|---|---|---|---|---|
Sample LC#1 | ||||||
LC #1 ACP | Replicate #1 | 190,135 | 64.45% | 122,539 | 1,152 | 90.59% |
Replicate #2 | 160,040 | 68.63% | 109,838 | 1,044 | 92.64% | |
Replicate #3 | 191,567 | 68.23% | 130,703 | 1,232 | 91.92% | |
Sample LC#1 | ||||||
LC #2 ACP | Replicate #1 | 257,591 | 70.71% | 182,132 | 1,027 | 84.01% |
Sample EC#1 | ||||||
EC #1 NDS | Replicate #1 | 503,058 | 98.54% | 495,705 | 5,131 | 93.90% |
EC #1 ACP | Replicate #1 | 429,481 | 69.23% | 297,322 | 2,795 | 89.44% |
LC: Lung cancer; ACP: Ampliseq custom panel; NDS: NextDay Seq PAN Cancer panel.